This inventor holds 2 USPTO granted patents. Top assignee: Fundacao Oswaldo Cruz-Fiocruz. Active years: 2013-2014.
Company Filing History:
Years Active: 2013-2014
Title: Ivan Neves, Jr: Innovator in Pharmaceutical Compounds
Introduction
Ivan Neves, Jr. is a notable inventor based in Rio de Janeiro, Brazil. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds used for treating serious diseases. With a total of 2 patents, his work is recognized for its potential impact on public health.
Latest Patents
One of Ivan's latest patents involves azole compounds used as tuberculostatic and leishmanicide agents. This invention refers to new 1,2,3-triazole and imidazole compounds included in the families of compounds represented by general formula VIII. The patent also covers a pharmaceutical composition comprising at least one of the azole compounds represented by the general formula VIII, along with the use of such compositions and methods for the treatment or inhibition of tuberculosis and leishmaniasis.
Career Highlights
Ivan Neves, Jr. is affiliated with the Fundação Oswaldo Cruz (Fiocruz), a prominent research institution in Brazil. His work at Fiocruz has allowed him to focus on innovative solutions for pressing health issues. His contributions have been instrumental in advancing research in pharmaceutical sciences.
Collaborations
Ivan has collaborated with esteemed colleagues, including Maria Cristina Da Silva Lourenço and Marcelo Da Silva Genestra. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.
Conclusion
Ivan Neves, Jr. stands out as an influential inventor in the pharmaceutical industry, with a focus on developing innovative treatments for tuberculosis and leishmaniasis. His work continues to contribute to advancements in public health and the fight against infectious diseases.